ART0380
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ART0380, covering 2025-11-06 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]